The Magazine for Sleep Professionals
Friday, October 9, 2026
Aeroflow Sleep, a national durable medical equipment (DME) provider specializing in CPAP supplies, announced the results of a proprietary survey of 887 parents, which revealed a hidden health crisis happening due to parental sleep deprivation, with more than a quarter of respondents showcasing signs of undiagnosed sleep apnea. Parents are […]
“Sleep-maxxing” is framed as a commitment to wellness, however clinical evidence suggests this hyper-fixation often functions as a catalyst for sleep impairment. The 2026 American Journal of Lifestyle Medicine review emphasizes that sleep is a process best supported by circadian rhythm alignment and low physiological arousal. When individuals impose rigid […]
Most sleep clinicians know the evidence for slow-paced breathing. Fewer have found a practical way to get patients to actually do it consistently, in the dark, without reaching for their phone. That gap is what moonbird was designed to close. Moonbird is a handheld tactile breath pacer: it expands and […]
New survey results from the American Academy of Sleep Medicine explore the complex relationship between marijuana use and sleep. One-third (33%) of adults reported that their sleep is slightly or significantly better when they use marijuana. In contrast, 19% of adults reported either no impact (11%) or that their sleep is […]
Sleep.ai announced findings from a peer-reviewed study led by Washington State University, in collaboration with the University of Washington, exploring sleep patterns in people with chronic insomnia. It is the longest known objective, real-world characterization of objective sleep in chronic insomnia. Published in JMIR Formative Research, the study tracked 112 adults […]
Nexalin Technology, Inc. announced the online publication of a peer-reviewed study in Psychotherapy and Psychosomatics reporting significant clinical improvement and measurable brain-network modulation in patients with chronic insomnia treated with the Company’s high-power 15 mA, 77.5 Hz stimulation approach. The paper was published online on April 20, 2026. The study, titled: “Modulating […]
Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]
Idorsia Ltd announces that its novel treatment for insomnia disorder QUVIVIQ (Daridorexant) has been awarded the inaugural Prix Galien Bridges Award in the category of “Best Biotechnology & Pharmaceutical Product”. The award recognizes groundbreaking medicines, including biologics, gene therapies, and traditional pharmaceutical compounds, that advance patient care through scientific innovation. […]
Social media trends have become increasingly influential – even changing bedtime routines and sleep habits for many Americans. According to a 2025 survey from the American Academy of Sleep Medicine, 56% of U.S. adults have tried one of this year’s viral social media trends related to sleep. “Bed rotting,” which is […]
SleepSpace (Proactive Life, Inc.), an AI-powered sleep technology company founded by NIH-funded sleep scientist Dr. Daniel Gartenberg, PhD, announced it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The award supports development of […]
